Supplemental material
OncoImmunology
Volume 12, 2023 - Issue 1
Open access
1,526
Views
0
CrossRef citations to date
0
Altmetric
Original Research
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma
Azar Rezapoura Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Swedenhttps://orcid.org/0000-0002-7355-1474View further author information
, Daniel Rydbeckb Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden;c Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenView further author information
, Fabian Byvalda Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Swedenhttps://orcid.org/0000-0003-0516-5448View further author information
, Viktor Tasseliusc Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;d Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Swedenhttps://orcid.org/0000-0002-1445-5220View further author information
, Gustaf Danielssone Department of Clinical Pathology and Genetics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenView further author information
, Eva Angeneteb Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden;c Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenCorrespondence[email protected]
https://orcid.org/0000-0001-9966-4904View further author information
& https://orcid.org/0000-0001-9966-4904View further author information
Ulf Yrlida Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenCorrespondence[email protected]
https://orcid.org/0000-0002-3431-6770View further author information
show allhttps://orcid.org/0000-0002-3431-6770View further author information
Article: 2209473
|
Received 28 Feb 2023, Accepted 27 Apr 2023, Published online: 10 May 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.